Girentuximab

Girentuximab
Trade Name Rencarex
Orphan Indication Renal cancer
USA Market Approval USA
USA Designation Date 2001-03-22 00:00:00
Sponsor Heidelberg Pharma AG;101 Schriesheimer Stra´┐Że;Ladenburg